Nordic Society of Paediatric Haematology and Oncology (NOPHO) Radiotherapy Working Group consensus guidelines on radiotherapy for paediatric low-grade gliomas
DOI:
https://doi.org/10.2340/1651-226X.2026.44815Keywords:
Radiotherapy, paediatrics, brain neoplasms, practice guidelineAbstract
Background and purpose: Paediatric low-grade gliomas (pLGG) are the most common brain tumours in children. Radiotherapy, once the standard treatment for unresectable pLGG, is now used less frequently due to concerns about late side effects. The Nordic Society of Paediatric Haematology and Oncology (NOPHO) Radiotherapy Working Group aims to provide consensus guidelines on the use of radiotherapy for pLGG, addressing the current controversies and facilitating decision-making.
Patient/material and methods: The guidelines were developed by clinical/radiation oncologists from the Nordic and Baltic countries and two international experts during a 2-day working group meeting. The meeting included presentations from the international experts and was preceded by a survey on radiotherapy practices and a non-systematic review of the literature on pLGG.
Results: We present consensus-based recommendations for radiotherapy of pLGG. The guidelines discuss indications and timing of radiotherapy, age-related considerations, and the impact of genetic predisposition disorders such as neurofibromatosis type 1. Modern radiotherapy techniques, such as proton therapy, are highlighted for their potential to reduce long-term side effects.
Interpretation: Radiotherapy remains the most effective treatment for unresectable pLGG, but its use must be carefully weighed against the risk of long-term side effects. The guidelines emphasise a personalised treatment approach, considering the evolving field of targeted therapies and the importance of multidisciplinary input in decision-making.
Downloads
References
Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016–2020. Neuro Oncol. 2023;25(12 Suppl. 2):iv1–99.
https://doi.org/10.1093/neuonc/noad149 DOI: https://doi.org/10.1093/neuonc/noad149
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231–51.
https://doi.org/10.1093/neuonc/noab106 DOI: https://doi.org/10.1093/neuonc/noab106
Fangusaro J, Jones DT, Packer RJ, Gutmann DH, Milde T, Witt O, et al. Pediatric low-grade glioma: state-of-the-art and ongoing challenges. Neuro Oncol. 2024;26(1):25–37.
https://doi.org/10.1093/neuonc/noad195 DOI: https://doi.org/10.1093/neuonc/noad195
Wisoff JH, Sanford RA, Heier LA, Sposto R, Burger PC, Yates AJ, et al. Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children’s Oncology Group. Neurosurgery. 2011;68(6):1548–54; discussion 54–5.
https://doi.org/10.1227/NEU.0b013e318214a66e DOI: https://doi.org/10.1227/NEU.0b013e318214a66e
Roka K, Scheinemann K, Avula S, Maduro JH, Thomale UW, Sehested A, et al. European standard clinical practice recommendations for primary pediatric low-grade gliomas. EJC Paediatr Oncol. 2024;4:100169.
https://doi.org/10.1016/j.ejcped.2024.100169 DOI: https://doi.org/10.1016/j.ejcped.2024.100169
Acharya S, Liu JF, Tatevossian RG, Chiang J, Qaddoumi I, Gajjar A, et al. Risk stratification in pediatric low-grade glioma and glioneuronal tumor treated with radiation therapy: an integrated clinicopathologic and molecular analysis. Neuro Oncol. 2020;22(8):1203–13.
https://doi.org/10.1093/neuonc/noaa031 DOI: https://doi.org/10.1093/neuonc/noaa031
Sait SF, Giantini-Larsen AM, Tringale KR, Souweidane MM, Karajannis MA. Treatment of pediatric low-grade gliomas. Curr Neurol Neurosci Rep. 2023;23(4):185–99.
https://doi.org/10.1007/s11910-023-01257-3 DOI: https://doi.org/10.1007/s11910-023-01257-3
Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Marcus KJ, et al. Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer. 2014;61(7):1173–9.
https://doi.org/10.1002/pbc.24958 DOI: https://doi.org/10.1002/pbc.24958
Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, et al. Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma. N Engl J Med. 2016;374(14):1344–55.
https://doi.org/10.1056/NEJMoa1500925 DOI: https://doi.org/10.1056/NEJMoa1500925
Journy N, Indelicato DJ, Withrow DR, Akimoto T, Alapetite C, Araya M, et al. Patterns of proton therapy use in pediatric cancer management in 2016: an international survey. Radiother Oncol. 2019;132:155–61.
https://doi.org/10.1016/j.radonc.2018.10.022 DOI: https://doi.org/10.1016/j.radonc.2018.10.022
Brouwers MC, Kerkvliet K, Spithoff K, Consortium ANS. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 2016;352:i1152.
https://doi.org/10.1136/bmj.i1152 DOI: https://doi.org/10.1136/bmj.i1152
Bennebroek CAM, van Zwol J, Montauban van Swijndregt MC, Porro GL, Oostenbrink R, Dittrich ATM, et al. A retrospective, nationwide, multicenter study on diagnosis and treatment outcome of pediatric optic pathway/hypothalamic gliomas including analysis of risk factors for progression after systemic anticancer therapy. Cancers (Basel). 2025;17(5):716.
https://doi.org/10.3390/cancers17050716. DOI: https://doi.org/10.3390/cancers17050716
Merchant TE, Kun LE, Wu S, Xiong X, Sanford RA, Boop FA. Phase II trial of conformal radiation therapy for pediatric low-grade glioma. J Clin Oncol. 2009;27(22):3598–604.
https://doi.org/10.1200/JCO.2008.20.9494 DOI: https://doi.org/10.1200/JCO.2008.20.9494
Tsang DS, Murphy ES, Merchant TE. Radiation therapy for optic pathway and hypothalamic low-grade gliomas in children. Int J Radiat Oncol Biol Phys. 2017;99(3):642–51.
https://doi.org/10.1016/j.ijrobp.2017.07.023 DOI: https://doi.org/10.1016/j.ijrobp.2017.07.023
Lassaletta A, Zapotocky M, Bouffet E. Chemotherapy in pediatric low-grade gliomas (PLGG). Childs Nerv Syst. 2024;40(10):3229–39.
https://doi.org/10.1007/s00381-024-06458-w DOI: https://doi.org/10.1007/s00381-024-06458-w
Merchant TE, Conklin HM, Wu S, Lustig RH, Xiong X. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol. 2009;27(22):3691–7.
https://doi.org/10.1200/JCO.2008.21.2738 DOI: https://doi.org/10.1200/JCO.2008.21.2738
Greenberger BA, Pulsifer MB, Ebb DH, MacDonald SM, Jones RM, Butler WE, et al. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2014;89(5):1060–8.
https://doi.org/10.1016/j.ijrobp.2014.04.053 DOI: https://doi.org/10.1016/j.ijrobp.2014.04.053
de Blank P, Bandopadhayay P, Haas-Kogan D, Fouladi M, Fangusaro J. Management of pediatric low-grade glioma. Curr Opin Pediatr. 2019;31(1):21–7.
https://doi.org/10.1097/MOP.0000000000000717 DOI: https://doi.org/10.1097/MOP.0000000000000717
Traunwieser T, Kandels D, Pauls F, Pietsch T, Warmuth-Metz M, Bison B, et al. Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studies. Neurooncol Adv. 2020;2(1):vdaa094.
https://doi.org/10.1093/noajnl/vdaa094 DOI: https://doi.org/10.1093/noajnl/vdaa094
Bhatia S, Chen Y, Wong FL, Hageman L, Smith K, Korf B, et al. Subsequent neoplasms after a primary tumor in individuals with neurofibromatosis type 1. J Clin Oncol. 2019;37(32):3050–8.
https://doi.org/10.1200/JCO.19.00114 DOI: https://doi.org/10.1200/JCO.19.00114
Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007;68(12):932–8.
https://doi.org/10.1212/01.wnl.0000257095.33125.48 DOI: https://doi.org/10.1212/01.wnl.0000257095.33125.48
Ajithkumar T, Taylor R, Kortmann RD. Radiotherapy in the management of paediatric low-grade gliomas. Clin Oncol (R Coll Radiol). 2019;31(3):151–61.
https://doi.org/10.1016/j.clon.2018.11.032 DOI: https://doi.org/10.1016/j.clon.2018.11.032
Indelicato DJ, Rotondo RL, Uezono H, Sandler ES, Aldana PR, Ranalli NJ, et al. Outcomes following proton therapy for pediatric low-grade glioma. Int J Radiat Oncol Biol Phys. 2019;104(1):149–56.
https://doi.org/10.1016/j.ijrobp.2019.01.078 DOI: https://doi.org/10.1016/j.ijrobp.2019.01.078
Gnekow AK, Kandels D, Tilburg CV, Azizi AA, Opocher E, Stokland T, et al. SIOP-E-BTG and GPOH guidelines for diagnosis and treatment of children and adolescents with low grade glioma. Klin Padiatr. 2019;231(3):107–35.
https://doi.org/10.1055/a-0889-8256 DOI: https://doi.org/10.1055/a-0889-8256
Muller K, Gnekow A, Falkenstein F, Scheiderbauer J, Zwiener I, Pietsch T, et al. Radiotherapy in pediatric pilocytic astrocytomas. A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH). Strahlenther Onkol. 2013;189(8):647–55.
https://doi.org/10.1007/s00066-013-0357-7 DOI: https://doi.org/10.1007/s00066-013-0357-7
Paulino AC, Mazloom A, Terashima K, Su J, Adesina AM, Okcu MF, et al. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. Cancer. 2013;119(14):2654–9.
https://doi.org/10.1002/cncr.28118 DOI: https://doi.org/10.1002/cncr.28118
Haas-Kogan D, Indelicato D, Paganetti H, Esiashvili N, Mahajan A, Yock T, et al. National cancer institute workshop on proton therapy for children: considerations regarding brainstem injury. Int J Radiat Oncol Biol Phys. 2018;101(1):152–68.
https://doi.org/10.1016/j.ijrobp.2018.01.013 DOI: https://doi.org/10.1016/j.ijrobp.2018.01.013
Cooper BT, Mayo CS, Milano MT, Olch AJ, Oh C, Keating GF, et al. Predictive factors associated with radiation myelopathy in pediatric patients with cancer: a PENTEC comprehensive review. Int J Radiat Oncol Biol Phys. 2024;119(2):494–6.
https://doi.org/10.1016/j.ijrobp.2023.12.020 DOI: https://doi.org/10.1016/j.ijrobp.2023.12.020
Shen CJ, Kry SF, Buchsbaum JC, Milano MT, Inskip PD, Ulin K, et al. Retinopathy, optic neuropathy, and cataract in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review. Int J Radiat Oncol Biol Phys. 2024;119(2):431–45.
https://doi.org/10.1016/j.ijrobp.2023.06.007 DOI: https://doi.org/10.1016/j.ijrobp.2023.06.007
Scoccianti S, Detti B, Gadda D, Greto D, Furfaro I, Meacci F, et al. Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist’s guide for delineation in everyday practice. Radiother Oncol. 2015;114(2):230–8.
https://doi.org/10.1016/j.radonc.2015.01.016 DOI: https://doi.org/10.1016/j.radonc.2015.01.016
Wheeler G, Grassberger C, Samers J, Dwyer M, Wiltshire K, Daly P, et al. Central endocrine complications among childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review. Int J Radiat Oncol Biol Phys. 2024;119(2):457–66.
https://doi.org/10.1016/j.ijrobp.2023.04.024 DOI: https://doi.org/10.1016/j.ijrobp.2023.04.024
Murphy B, Jackson A, Bass JK, Tsang DS, Ronckers CM, Kremer L, et al. Modeling the risk of hearing loss from radiation therapy in childhood cancer survivors: a PENTEC comprehensive review. Int J Radiat Oncol Biol Phys. 2024;119(2):446–56.
https://doi.org/10.1016/j.ijrobp.2023.08.016 DOI: https://doi.org/10.1016/j.ijrobp.2023.08.016
Waxer JF, Wong K, Modiri A, Charpentier AM, Moiseenko V, Ronckers CM, et al. Risk of cerebrovascular events among childhood and adolescent patients receiving cranial radiation therapy: a PENTEC normal tissue outcomes comprehensive review. Int J Radiat Oncol Biol Phys. 2024;119(2):417–30.
https://doi.org/10.1016/j.ijrobp.2022.06.079 DOI: https://doi.org/10.1016/j.ijrobp.2022.06.079
El-Fayech C, Haddy N, Allodji RS, Veres C, Diop F, Kahlouche A, et al. Cerebrovascular diseases in childhood cancer survivors: role of the radiation dose to willis circle arteries. Int J Radiat Oncol Biol Phys. 2017;97(2):278–86.
https://doi.org/10.1016/j.ijrobp.2016.10.015 DOI: https://doi.org/10.1016/j.ijrobp.2016.10.015
Hoeben BA, Carrie C, Timmermann B, Mandeville HC, Gandola L, Dieckmann K, et al. Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group. Lancet Oncol. 2019;20(3):e155–66.
https://doi.org/10.1016/S1470-2045(19)30034-8 DOI: https://doi.org/10.1016/S1470-2045(19)30034-8
Perwein T, Benesch M, Kandels D, Pietsch T, Schmidt R, Quehenberger F, et al. High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study group. Neuro Oncol. 2021;23(7):1148–62.
https://doi.org/10.1093/neuonc/noaa296 DOI: https://doi.org/10.1093/neuonc/noaa296
Brisson RJ, Indelicato DJ, Bradley JA, Aldana PR, Klawinski D, Morris CG, et al. Long-term outcomes following proton therapy for pediatric spinal low-grade glioma. Pediatr Blood Cancer. 2024;71(12):e31341.
https://doi.org/10.1002/pbc.31341 DOI: https://doi.org/10.1002/pbc.31341
Tsang DS, Murphy ES, Ezell SE, Lucas JT, Jr, Tinkle C, Merchant TE. Craniospinal irradiation for treatment of metastatic pediatric low-grade glioma. J Neurooncol. 2017;134(2):317–24.
https://doi.org/10.1007/s11060-017-2525-6 DOI: https://doi.org/10.1007/s11060-017-2525-6
Otth M, Scheinemann K, Ajithkumar T, Aquilina K, Avula S, Gan H-W, et al. Overview of European standard clinical practice recommendations for multidiscplinary teams involved in the treatment of central nervous system tumours in children and adolescents – SIOPE Brain Tumour Group. EJC Paediatr Oncol. 2024;3:100166.
https://doi.org/10.1016/j.ejcped.2024.100166 DOI: https://doi.org/10.1016/j.ejcped.2024.100166
Kiss-Miki R, Obeidat M, Mate V, Teutsch B, Agocs G, Kiss-Dala S, et al. Proton or photon? Comparison of survival and toxicity of two radiotherapy modalities among pediatric brain cancer patients: a systematic review and meta-analysis. PLoS One. 2025;20(2):e0318194.
https://doi.org/10.1371/journal.pone.0318194 DOI: https://doi.org/10.1371/journal.pone.0318194
Mohamad O, Wardak Z, Bowers DC, Le AH, Dan T, Abdulrahman R, et al. Margin-free fractionated stereotactic radiation therapy for pediatric brain tumors. Pract Radiat Oncol. 2020;10(6):e485–94.
https://doi.org/10.1016/j.prro.2020.03.013 DOI: https://doi.org/10.1016/j.prro.2020.03.013
van Aken ESM, Devnani B, Castelo-Branco L, De Ruysscher D, Martins-Branco D, Marijnen CAM, et al. ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or immunotherapy. Radiother Oncol. 2025;208:110910.
https://doi.org/10.1016/j.radonc.2025.110910 DOI: https://doi.org/10.1016/j.radonc.2025.110910
Tsang DS, Murphy ES, Lucas JT, Jr, Lagiou P, Acharya S, Merchant TE. Pseudoprogression in pediatric low-grade glioma after irradiation. J Neurooncol. 2017;135(2):371–9.
https://doi.org/10.1007/s11060-017-2583-9 DOI: https://doi.org/10.1007/s11060-017-2583-9
Stock A, Hancken CV, Kandels D, Kortmann RD, Dietzsch S, Timmermann B, et al. Pseudoprogression is frequent after front-line radiation therapy in pediatric low-grade glioma: results from the German low-grade glioma cohort. Int J Radiat Oncol Biol Phys. 2022;112(5):1190–202.
https://doi.org/10.1016/j.ijrobp.2021.12.007 DOI: https://doi.org/10.1016/j.ijrobp.2021.12.007
Eichkorn T, Bauer J, Bahn E, Lischalk JW, Meixner E, Sandrini E, et al. Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults. Radiother Oncol. 2022;172:54–64.
https://doi.org/10.1016/j.radonc.2022.05.005 DOI: https://doi.org/10.1016/j.radonc.2022.05.005
Mahajan A, Stavinoha PL, Rongthong W, Brodin NP, McGovern SL, El Naqa I, et al. Neurocognitive effects and necrosis in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review. Int J Radiat Oncol Biol Phys. 2024;119(2):401–16.
https://doi.org/10.1016/j.ijrobp.2020.11.073 DOI: https://doi.org/10.1016/j.ijrobp.2020.11.073
Williams NL, Rotondo RL, Bradley JA, Pincus DW, Fort JA, Wynn T, et al. Late effects after radiotherapy for childhood low-grade glioma. Am J Clin Oncol. 2018;41(3):307–12.
https://doi.org/10.1097/COC.0000000000000267 DOI: https://doi.org/10.1097/COC.0000000000000267
Rodrigues AJ, Jin MC, Wu A, Bhambhvani HP, Li G, Grant GA. Risk of secondary neoplasms after external-beam radiation therapy treatment of pediatric low-grade gliomas: a SEER analysis, 1973–2015. J Neurosurg Pediatr. 2021;28(3):306–14.
https://doi.org/10.3171/2021.1.PEDS20859 DOI: https://doi.org/10.3171/2021.1.PEDS20859
Ris MD, Leisenring WM, Goodman P, Di C, Noll J, Levy W, et al. Neuropsychological and socioeconomic outcomes in adult survivors of pediatric low-grade glioma. Cancer. 2019;125(17):3050–8.
https://doi.org/10.1002/cncr.32186 DOI: https://doi.org/10.1002/cncr.32186
Casey DL, Vogelius IR, Brodin NP, Roberts KB, Avanzo M, Moni J, et al. Risk of subsequent neoplasms in childhood cancer survivors after radiation therapy: a PENTEC comprehensive review. Int J Radiat Oncol Biol Phys. 2024;119(2):640–54.
https://doi.org/10.1016/j.ijrobp.2023.07.025 DOI: https://doi.org/10.1016/j.ijrobp.2023.07.025
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Anna Embring, Tanja Skyttä, Jacob Engellau, Irina Kerna, Daiva Sendiuliene, Malin Blomstrand, Daniel J. Indelicato, Beate Timmermann, Yasmin Lassen-Ramshad, Henriette Magelssen
This work is licensed under a Creative Commons Attribution 4.0 International License.
